NCT06697262

Brief Summary

The goal of this clinical trial is to evaluate the feasibility of the study, measured by the acceptability rate of patients to be recruited in a study proposing temperature monitoring at home, by a remote monitoring device or by the visit of an IDE at home (in association with the usual educational sessions), to children at risk of febrile neutropenia, from families with psycho-social vulnerabilities. The main questions it aims to answer are:

  • Will participants adhere to the telemonitoring system?
  • Is the intervention feasible, in terms of the device's failure to record temperature data?
  • Will parents behave appropriately when using the device?
  • How satisfied will parents and caregivers be?
  • What will be the physical tolerance of the device?
  • On an exploratory basis, will the remote monitoring system be effective for months? Researchers will compare :
  • patients using the telemonitoring device for continuous temperature monitoring at home, in combination with education sessions on temperature monitoring and the device
  • with patient with temperature monitoring at home by a nurse, 2 times a day, in combination with education sessions on temperature monitoring (without the telemonitoring device at home)

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
24mo left

Started May 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026May 2028

First Submitted

Initial submission to the registry

November 18, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
1.4 years until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2028

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

November 18, 2024

Last Update Submit

January 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • study acceptability rate

    number of patients included/number of eligible patients offered the study.

    24 months

Study Arms (2)

remote temperature monitoring device

EXPERIMENTAL
Device: Remote temperature monitoring device

home temperature monitoring by a nurse

ACTIVE COMPARATOR
Diagnostic Test: Home temperature monitoring by a nurse

Interventions

* Home temperature monitoring by a nyrse, twice a day, * In association with education sessions on temperature monitoring.

home temperature monitoring by a nurse

* Use of the Tucky® remote monitoring device for continuous temperature monitoring at home, * In combination with education sessions on temperature monitoring and the device.

remote temperature monitoring device

Eligibility Criteria

Age0 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patient
  • Aged 0 to 17 inclusive
  • Followed in the Pediatric Onco-Hematology Department
  • Primo-diagnosed with solid or hematological cancer (incident case)
  • Having received a first cycle of chemotherapy
  • Whose family has psycho-social vulnerabilities assessed by the Froger et al. tool, indicating a need for an IDE to support the family in monitoring the patient.

You may not qualify if:

  • Patient:
  • with a dermatosis contraindicating the use of the device
  • Refusing to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Febrile Neutropenia

Condition Hierarchy (Ancestors)

NeutropeniaAgranulocytosisLeukopeniaCytopeniaHematologic DiseasesHemic and Lymphatic DiseasesLeukocyte Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 20, 2024

Study Start

May 1, 2026

Primary Completion (Estimated)

May 4, 2028

Study Completion (Estimated)

May 4, 2028

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share